Top

Tag: discount


Pricing, Regulations

Alzheimer’s drug Leqembi to launch at discount to Aduhelm

January 9, 2023

Via: Pharmaphorum

The US regulator has granted accelerated approval to anti-amyloid therapy Leqembi (lecanemab) with a fairly broad label to treat patients in the mild cognitive impairment or mild dementia stage of disease who have confirmed presence of amyloid pathology. Eisai and […]